Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jun 28;50(4):1108-1117.
doi: 10.1093/ageing/afab024.

Reasons for discontinuing oral anticoagulation therapy for atrial fibrillation: a systematic review

Jackie Buck  1   2 , Julia Fromings Hill  1 , Alison Martin  3 , Cassandra Springate  3 , Bikramaditya Ghosh  3 , Rachel Ashton  4 , Gerry Lee  5 , Andrzei Orlowski  6
Affiliations

Reasons for discontinuing oral anticoagulation therapy for atrial fibrillation: a systematic review

Jackie Buck et al. Age Ageing. .

Abstract

Introduction: Atrial fibrillation (AF) is the most common cardiac arrhythmia and can lead to significant comorbidities and mortality. Persistence with oral anticoagulation (OAC) is crucial to prevent stroke but rates of discontinuation are high. This systematic review explored underlying reasons for OAC discontinuation.

Methods: A systematic review was undertaken to identify studies that reported factors influencing discontinuation of OAC in AF, in 11 databases, grey literature and backwards citations from eligible studies published between 2000 and 2019. Two reviewers independently screened titles, abstracts and papers against inclusion criteria and extracted data. Study quality was appraised using Gough's weight of evidence framework. Data were synthesised narratively.

Results: Of 6,619 sources identified, 10 full studies and 2 abstracts met the inclusion criteria. Overall, these provided moderate appropriateness to answer the review question. Four reported clinical registry data, six were retrospective reviews of patients' medical records and two studies reported interviews and surveys. Nine studies evaluated outcomes relating to dabigatran and/or warfarin and three included rivaroxaban (n = 3), apixaban (n = 3) and edoxaban (n = 1). Bleeding complications and gastrointestinal events were the most common factors associated with discontinuation, followed by frailty and risk of falling. Patients' perspectives were seldom specifically assessed. Influence of family carers in decisions regarding OAC discontinuation was not examined.

Conclusion: The available evidence is derived from heterogeneous studies with few relevant data for the newer direct oral anticoagulants. Reasons underpinning decision-making to discontinue OAC from the perspective of patients, family carers and clinicians is poorly understood.

Keywords: adherence; atrial fibrillation; discontinuation; older people; oral anticoagulation.

PubMed Disclaimer

Figures

Figure 1
Figure 1
PRISMA flowchart.
Figure 2
Figure 2
Classification of data.
Figure 3
Figure 3
Inter-relationship of reasons for discontinuation.
See this image and copyright information in PMC

References

    1. Ruigómez A, Johansson S, Wallander MA, García Rodríguez LA. Risk of mortality in a cohort of patients newly diagnosed with chronic atrial fibrillation. BMC Cardiovasc Disord 2002; 2: 5. - PMC - PubMed
    1. Velleca M, Costa G, Goldstein L, Bishara M, Ming B. A review of the burden of atrial fibrillation: understanding the impact of the new millennium epidemic across Europe. Eur Med J 2019; 7: 110–8.
    1. Lane DA, Skjøth F, Lip GYH, Larsen TB, Kotecha D. Temporal trends in incidence, prevalence, and mortality of atrial fibrillation in primary care. J Am Heart Assoc 2017; 6: e005155. - PMC - PubMed
    1. Chugh SS, Havmoeller R, Narayanan K et al. Worldwide epidemiology of atrial fibrillation: a global burden of disease 2010 study. Circulation 2014; 129: 837–47. - PMC - PubMed
    1. Colilla S, Crow A, Petkun W, Singer DE, Simon T, Liu X. Estimates of current and future incidence and prevalence of atrial fibrillation in the U.S. adult population. Am J Cardiol 2013; 112: 1142–7. - PubMed

Publication types